Eduardo S. De Camargo Magalhaes
Rio De Janeiro, RJ 21949590, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.
Journal: Leukemia
Published: August 11, 2025
Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 23, 2024
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy.
Journal: Leukemia
Published: November 18, 2023
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
Journal: International journal of molecular sciences
Published: February 08, 2023
CCL21-CCR7 signaling promotes microglia/macrophage recruitment and chemotherapy resistance in glioblastoma.
Journal: Cellular and molecular life sciences : CMLS
Published: January 28, 2023
The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity.
Journal: Journal of cell science
Published: March 05, 2021
CREB signaling activity correlates with differentiation and survival in medulloblastoma.
Journal: Scientific reports
Published: September 15, 2020
The multiple functions of the co-chaperone stress inducible protein 1.
Journal: Cytokine & growth factor reviews
Published: April 28, 2020
Glioblastoma Therapy in the Age of Molecular Medicine.
Journal: Trends in cancer
Published: December 21, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026